Advanced Therapy Medicinal Product Technology Development Center

The Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC) is a specialized facility in Taiwan dedicated to the advancement and commercialization of cell and gene therapies. Operating under the Development Center for Biotechnology (DCB), the center provides comprehensive CDMO services, including process development, analytical testing, and GMP-compliant manufacturing for advanced therapeutic medicinal products. It focuses on accelerating the translation of innovative modalities, such as CAR-T cells and mesenchymal stem cells, from academic research into clinical applications. The center also offers regulatory consulting and quality control services to help biotech partners navigate the complex approval landscape for ATMPs. By bridging the gap between laboratory discovery and large-scale production, ATMP-TDC serves as a critical hub for the life sciences ecosystem in the Asia-Pacific region.